Please login to the form below
GW Pharma's cannabis-based medicine to be tested in dementia
Trial will be funded by Alzheimer’s Research UK
AZ says dropping MedImmune will help ‘streamline’ its R&D
Will also drop other candidates that haven’t hit the mark
Merck puts prostate cancer firmly in Keytruda’s sights
Lynparza combination could open up huge new market
Biosimilar Herceptin helps Roche gain new Perjeta recommendation
NICE decision puts NHS in vanguard for new use
FCB Health’s Neon attracts new managing director
Mardene Miller will lead the agency with co-managing director Kevin McHale
Lucid Group acquires digital and creative agency Bluedog
The move comes as the group celebrates its 12-year anniversary
Novartis first to benefit from NICE advice on ‘patient preference’
Consultancy spin-off looking to expand services
Teva will have to endure revenue 'trough' in 2019
Company looks to migrane treatment Ajovy for growth
Cancer drugs and China sustain AZ’s return to growth
Tagrisso set to become biggest seller
Q&A: Pernille Laerkegaard Hansen
Gemma Jones interviews AstraZeneca's Senior Research Director, Head of Bioscience
-
‘Post-Brexit landscape for EU-wide IP Rights: The Story So Far’Brexit means pharma must review its intellectual property rights across Europe
-
The shifting healthcare landscape
-
Communiqué Awards 2019 accepting entriesEntrants can choose to submit work in 29 categories
-
Keytruda combo outshines Opdivo in kidney cancerBMS also on the backfoot after Nektar data release
-
Bicycle Therapeutics to tackle AMR with government fundingBiotech to discover new class of antibacterial agents
-
Medicinal cannabis firm Althea enters UK marketIt will start supplying products next month
-
FDA panel backs J&J’s new-class antidepressantSet to be first novel antidepressant approved since Prozac in 1987
-
AbbVie enters BCMA race with Teneobio dealAgreement includes option to acquire TeneoOne
-
Industry aghast as EU Parliament backs biosimilar rule changeThe change could come into effect in 2021
Latest appointments
-
New faces at BioStrata, P\S\L Group and FCB HealthThe latest movers in healthcare comms
-
New faces at GCI Health, Porterhouse Medical and Research PartnershipThe latest movers in healthcare communications
-
New hires at Ferring, Flexion and Immunocore The latest movers in pharma
-
New faces at Lucid, 90Ten and Page & Page The latest movers in med comms
-
New hires at Nanoform, Leo Pharma and CalliditasThe latest movers in pharma and biotech
Featured jobs
-
Senior Medical Writer
-
Great salary and benefits
- Editorial Assistant Medical Education Agency
-
£25, 000 - £26, 000
-
Project Manager/ Account Manager
-
Salary TBC
-
Senior Medical Writer
-
Salary TBC
-
Digital Account Director
-
Salary TBC
-
Account Director, Medical Education
-
Salary TBC
-
Senior Medical Writer
-
Up to £50, 000 with Benefits
- Account Manager, Medical Communications and Marketing
-
£30, 000 – £40, 000 benefits and bonus
Subscribe to our email news alerts
- Lighthouse Medical Commuications US appoints Lisa Druce as its new Managing Partner
- GW Pharma's cannabis-based medicine to be tested in dementia
- International Childhood Cancer Day 2019
- AZ says dropping MedImmune will help ‘streamline’ its R&D
- Merck puts prostate cancer firmly in Keytruda’s sights
- Biosimilar Herceptin helps Roche gain new Perjeta recommendation
PMHub
Nobull Communications
Switched on Creative Communications. With an encyclopedic working knowledge of pharmaceutical industry rules and regulations, we create dynamic, intuitive and...
Latest intelligence
- International Childhood Cancer Day 2019
- The number of new cases per year is shocking but the journey and the outlooks have vastly improved. We've pulled together an infographic to show just what we mean with...
- Immuno-oncology in 2019: the rapid evolution continues
- Immunotherapy is pharma’s biggest growth driver – how will it develop in 2019?...
- Mixing up Focus Groups
- A nice spread of homogeneous participants in a focus groups are often a go to for reliable research outcomes but there's much to be said for mixing it up and...
Quick links
Infographics
